Impact of Organ Function-Based Clinical Trial Eligibility Criteria in Patients With Diffuse Large B-Cell Lymphoma: Who Gets Left Behind?
2021
PURPOSEExclusion of patients needing urgent treatment or requiring novel biomarkers before enrollment has impacted the ability to enroll real-world patients in frontline trials of diffuse large B-c...
Keywords:
-
Correction
-
Source
-
Cite
-
Save
27
References
4
Citations
NaN
KQI